BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
BRUIN CLL-313:一项随机III期临床试验,比较吡托布替尼与苯达莫司汀联合利妥昔单抗治疗未经治疗的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的疗效。
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-02380
Jurczak, Wojciech; Kwiatek, Michal; Czyz, Jaroslaw; Roberto de Mattos, Ederson; Eom, Ki-Seong; Egle, Alexander; Panovska, Anna; Popova, Zhanet Grudeva; Shih, Hsuan-Jen; Casado Montero, Luis Felipe; Sportoletti, Paolo; Hua, Vu Minh; D'Olimpio, James T; Iida, Shinsuke; Ito, Rodrigo; Bao, Katherine; Fink, Anne; Su, Weiji; Ruppert, Amy S; Levy, Alejandro; Wrobel, Tomasz